Conduit Pharmaceuticals Inc. (CDTTW) — DEF 14A Filings
All DEF 14A filings from Conduit Pharmaceuticals Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Conduit Pharma Seeks Share Reserve Boost, Board Election at August AGM
— Jul 8, 2025 Risk: medium
CONDUIT PHARMACEUTICALS INC. (CDTTW) filed a Definitive Proxy Statement (DEF 14A) on July 8, 2025, outlining proposals for its virtual annual meeting on August -
Conduit Pharmaceuticals Files Definitive Proxy Statement
— Dec 6, 2024 Risk: low
Conduit Pharmaceuticals Inc. filed its definitive proxy statement on December 9, 2024, for the fiscal year ending December 31, 2024. The company, formerly known -
Conduit Pharmaceuticals Files Definitive Proxy Statement
— Oct 28, 2024 Risk: low
Conduit Pharmaceuticals Inc. filed its definitive proxy statement on October 28, 2024, for the fiscal year ending December 31, 2024. The company, formerly known
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX